MDI-0151

N/A

Report date: 2024/07/04 18:03:12
NMEFirst In Class

Base Information

Drug NameMDI-0151
Drug Alias NameMDI-0151MOD-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlivexis Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A